Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Use of Dual-Energy X-ray Absorptiometry in Children with Inflammatory Bowel Disease: A Large Single Centre Study

  • Jois, Asha (Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital) ;
  • Perera, Sajini (General Medicine, Royal Children's Hospital) ;
  • Simm, Peter (Department of Endocrinology, Royal Children's Hospital) ;
  • Alex, George (Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital)
  • Received : 2022.02.10
  • Accepted : 2022.08.23
  • Published : 2022.11.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Low bone mineral density (BMD) is a complication in children with inflammatory bowel disease (IBD). There are limited data evaluating dual-energy x-ray absorptiometry (DXA) as a screening tool for low BMD in children with IBD. We performed a single site retrospective analysis of DXA use. Methods: Children aged 5-18 years with IBD diagnosed between 2013 to 2017 at the Royal Children's Hospital, Australia, were included. Patient demographics, measures of disease activity, DXA scores, and factors related to BMD were collected. Results: Over a median follow up of 5.1 (4-6.4) years, 72/239 (30.1%) children underwent DXA, and 28/239 (11.7%) children had a second DXA. Our DXA practice differed to consensus guidelines regarding initial screening based on height and/or body mass index (BMI) z-score (8/17 [47.1%]), and repeat surveillance (13/42 [31.0%]). Children had a median lumbar spine (LS) z-score -0.80 (-1.65-0.075). Children with LS z-score≤-2.0 (n=14) had lower weight (6.57 [1.78-23.7] vs. 51.1 [26.5-68.7], p=0.0002) and height centiles (3.62 [1.17-17.1] vs. 42 [16.9-67.1], p=0.0001), and higher faecal calprotectin (FCP) (3041 [1182-4192] vs. 585 [139-2419], p=0.009) compared to children with LS z-score>-2.0. No fractures were reported. Of 28 children who underwent a second DXA 1.6 (1.1-2.2) years following initial DXA, no significant change in z-scores occurred. Conclusion: Children with IBD had low BMD. In addition to height centile and weight centile, FCP was associated with lower BMD, and should be considered in DXA screening guidelines. Greater clinician awareness of DXA consensus guidelines is required. Future prospective studies are required.

Keywords

References

  1. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998;114:902-11. https://doi.org/10.1016/S0016-5085(98)70309-9
  2. Bernstein CN, Leslie WD. The pathophysiology of bone disease in gastrointestinal disease. Eur J Gastroenterol Hepatol 2003;15:857-64. https://doi.org/10.1097/00042737-200308000-00004
  3. Clark EM, Ness AR, Bishop NJ, Tobias JH. Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 2006;21:1489-95. https://doi.org/10.1359/jbmr.060601
  4. Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Makitie O. Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study. J Pediatr 2014;164:1436-43.e1. https://doi.org/10.1016/j.jpeds.2014.01.073
  5. Kappelman MD, Galanko JA, Porter CQ, Sandler RS. Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:1125-30. https://doi.org/10.1002/ibd.21472
  6. Baxter-Jones AD, Faulkner RA, Forwood MR, Mirwald RL, Bailey DA. Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. J Bone Miner Res 2011;26:1729-39. https://doi.org/10.1002/jbmr.412
  7. Wahner HW, Dunn WL, Brown ML, Morin RL, Riggs BL. Comparison of dual-energy x-ray absorptiometry and dual photon absorptiometry for bone mineral measurements of the lumbar spine. Mayo Clin Proc 1988;63:1075-84. https://doi.org/10.1016/S0025-6196(12)65502-5
  8. Pappa H, Thayu M, Sylvester F, Leonard M, Zemel B, Gordon C. Skeletal health of children and adolescents with inflammatory bowel disease [Erratum in: J Pediatr Gastroenterol Nutr 2012;54:571]. J Pediatr Gastroenterol Nutr 2011;53:11-25. https://doi.org/10.1097/MPG.0b013e31821988a3
  9. Harpavat M, Greenspan SL, O'Brien C, Chang CC, Bowen A, Keljo DJ. Altered bone mass in children at diagnosis of Crohn disease: a pilot study. J Pediatr Gastroenterol Nutr 2005;40:295-300. https://doi.org/10.1097/01.MPG.0000153278.98861.32
  10. Hill RJ, Brookes DS, Lewindon PJ, Withers GD, Ee LC, Connor FL, et al. Bone health in children with inflammatory bowel disease: adjusting for bone age. J Pediatr Gastroenterol Nutr 2009;48:538-43. https://doi.org/10.1097/MPG.0b013e31818cb4b6
  11. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 1998;42:188-94. https://doi.org/10.1136/gut.42.2.188
  12. Ronel N, Tzion RL, Orlanski-Meyer E, Shteyer E, Guz-Mark A, Assa A, et al. Clinical criteria can identify children with osteopenia in newly diagnosed Crohn disease. J Pediatr Gastroenterol Nutr 2021;72:270-5. https://doi.org/10.1097/MPG.0000000000002911
  13. Schmidt S, Mellstrom D, Norjavaara E, Sundh V, Saalman R. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:511-8. https://doi.org/10.1097/MPG.0b013e31825817a0
  14. Schmidt S, Mellstrom D, Norjavaara E, Sundh SV, Saalman R. Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden. Inflamm Bowel Dis 2009;15:1844-50. https://doi.org/10.1002/ibd.20962
  15. Sylvester FA, Wyzga N, Hyams JS, Davis PM, Lerer T, Vance K, et al. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:42-50. https://doi.org/10.1002/ibd.20006
  16. Rozes S, Guilmin-Crepon S, Alison M, Thomas E, Hugot JP, Viala J, et al. Bone health in pediatric patients with Crohn disease. J Pediatr Gastroenterol Nutr 2021.73:231-5. https://doi.org/10.1097/MPG.0000000000003132
  17. Pichler J, Hanslik A, Huber WD, Aufricht C, Bidmon-Fliegenschnee B. Paediatric patients with inflammatory bowel disease who received infliximab experienced improved growth and bone health. Acta Paediatr 2014;103:e69-75. https://doi.org/10.1111/apa.12448
  18. Sigurdsson GV, Schmidt S, Mellstrom D, Ohlsson C, Kindblom JM, Lorentzon M, et al. Bone mass development from childhood into young adulthood in patients with childhood-onset inflammatory bowel disease. Inflamm Bowel Dis 2017;23:2215-26. https://doi.org/10.1097/MIB.0000000000001277
  19. Gupta A, Paski S, Issenman R, Webber C. Lumbar spine bone mineral density at diagnosis and during follow-up in children with IBD. J Clin Densitom 2004;7:290-5. https://doi.org/10.1385/JCD:7:3:290
  20. Guz-Mark A, Rinawi F, Egotubov O, Shimon I, Shamir R, Assa A. Pediatric-onset inflammatory bowel disease poses risk for low bone mineral density at early adulthood. Dig Liver Dis 2017;49:639-42. https://doi.org/10.1016/j.dld.2017.01.151
  21. Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S, et al. Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 2010;95:1265-73. https://doi.org/10.1210/jc.2009-2057
  22. Weber DR, Boyce A, Gordon C, Hogler W, Kecskemethy HH, Misra M, et al. The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD Official Position. J Clin Densitom 2019;22:567-89. https://doi.org/10.1016/j.jocd.2019.07.002
  23. Jones AR, Zacharin MR, Cameron FJ, Simm PJ. Bone density assessment in a tertiary paediatric centre over 13 years: Referral patterns and limitations. J Paediatr Child Health 2015;51:608-13. https://doi.org/10.1111/jpc.12789
  24. Paganelli M, Albanese C, Borrelli O, Civitelli F, Canitano N, Viola F, et al. Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2007;13:416-23. https://doi.org/10.1002/ibd.20039
  25. Walsham NE, Sherwood RA. Fecal calprotectin in inflammatory bowel disease. Clin Exp Gastroenterol 2016.9:21-9.